| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-05-27 16:24 Tx date 2026-05-22 |
$SVA
Sernova Biotherapeutics Inc. |
Sangha, Steven
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$41,600
+260,000 vol $0.16 each |
2,540,237 | |
| Filed 2026-05-27 16:21 Tx date 2026-05-22 |
$SVA
Sernova Biotherapeutics Inc. |
Brooks III, John Lawrence
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$36,625
+228,912 vol $0.16 each |
1,733,609 | |
| Filed 2026-05-27 16:20 Tx date 2026-05-22 |
$SVA
Sernova Biotherapeutics Inc. |
Brooks III, John Lawrence
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$57,600
+360,000 vol $0.16 each |
1,504,697 | |
| Filed 2026-05-27 16:18 Tx date 2026-05-22 |
$SVA
Sernova Biotherapeutics Inc. |
Paterson, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$31,076
+194,229 vol $0.16 each |
1,732,733 | |
| Filed 2026-05-27 16:17 Tx date 2026-05-22 |
$SVA
Sernova Biotherapeutics Inc. |
Paterson, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$41,600
+260,000 vol $0.16 each |
1,538,504 | |
| Filed 2026-05-27 16:14 Tx date 2026-05-22 |
$SVA
Sernova Biotherapeutics Inc. |
Muehlenweg, Bernd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$27,746
+173,418 vol $0.16 each |
1,735,081 | |
| Filed 2026-05-27 16:13 Tx date 2026-05-22 |
$SVA
Sernova Biotherapeutics Inc. |
Muehlenweg, Bernd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$41,600
+260,000 vol $0.16 each |
1,561,663 | |
| Filed 2026-05-27 16:09 Tx date 2026-05-22 |
$SVA
Sernova Biotherapeutics Inc. |
Lewis, Tanya
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$26,637
+166,482 vol $0.16 each |
1,559,775 | |
| Filed 2026-05-27 16:07 Tx date 2026-05-22 |
$SVA
Sernova Biotherapeutics Inc. |
Lewis, Tanya
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$41,600
+260,000 vol $0.16 each |
1,393,293 | |
| Filed 2026-04-17 12:49 Tx date 2026-04-16 |
$SVA
Sernova Biotherapeutics Inc. |
Sangha, Steven
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+26,666,667 vol |
52,666,668 | |
| Filed 2026-04-17 12:45 Tx date 2026-04-16 |
$SVA
Sernova Biotherapeutics Inc. |
Sangha, Steven
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$4,000,000
+26,666,667 vol $0.15 each |
49,703,667 | |
| Filed 2026-04-15 12:19 Tx date 2026-04-14 |
$SVA
Sernova Biotherapeutics Inc. |
Sangha, Steven
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+10,000,000 vol |
26,000,001 | |
| Filed 2026-04-15 12:16 Tx date 2026-04-14 |
$SVA
Sernova Biotherapeutics Inc. |
Sangha, Steven
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$1,500,000
+10,000,000 vol $0.15 each |
23,037,000 | |
| Filed 2026-04-15 12:04 Tx date 2026-04-14 |
$SVA
Sernova Biotherapeutics Inc. |
Rigby, Jonathan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+114,939 vol |
229,877 | |
| Filed 2026-04-15 12:02 Tx date 2026-04-14 |
$SVA
Sernova Biotherapeutics Inc. |
Rigby, Jonathan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+114,938 vol |
114,938 | |
| Filed 2026-04-15 12:01 Tx date 2024-05-28 |
$SVA
Sernova Biotherapeutics Inc. |
Rigby, Jonathan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-04-15 11:59 Tx date 2026-04-14 |
$SVA
Sernova Biotherapeutics Inc. |
Rigby, Jonathan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$43,676
+229,877 vol $0.19 each |
229,877 | |
| Filed 2026-04-15 11:57 Tx date 2024-05-28 |
$SVA
Sernova Biotherapeutics Inc. |
Rigby, Jonathan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-04-15 11:53 Tx date 2026-04-14 |
$SVA
Sernova Biotherapeutics Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+114,939 vol |
229,877 | |
| Filed 2026-04-15 11:49 Tx date 2026-04-14 |
$SVA
Sernova Biotherapeutics Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+114,938 vol |
114,938 |